Manchin Applauds Eli Lilly Decision to Cap Insulin Costs, Urges Other Drugmakers to Follow Suit
“I applaud this long-overdue announcement by Eli Lilly which will have an immediate impact on thousands of West Virginia families,” Senator Manchin said. “West Virginia has the highest percentage of adults with diagnosed diabetes of any state in the nation. No West Virginian or American should have to choose between insulin and food on their table or a roof over their heads. That’s why I fought to ensure the Inflation Reduction Act capped Medicare recipients’ insulin at $35 a month.
“While this announcement is great news for the Mountain State, we must continue to put pressure on drug manufacturers who charge Americans some of the highest drug prices in the world. I urge all manufacturers of insulin to do the right thing: cap the price of insulin and stop ripping off American consumers who depend on this life-saving drug.”
Next Article Previous Article
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.